293 related articles for article (PubMed ID: 19095135)
1. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
Bartunek J; Delrue L; Van Durme F; Muller O; Casselman F; De Wiest B; Croes R; Verstreken S; Goethals M; de Raedt H; Sarma J; Joseph L; Vanderheyden M; Weinberg EO
J Am Coll Cardiol; 2008 Dec; 52(25):2166-74. PubMed ID: 19095135
[TBL] [Abstract][Full Text] [Related]
2. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.
Demyanets S; Kaun C; Pentz R; Krychtiuk KA; Rauscher S; Pfaffenberger S; Zuckermann A; Aliabadi A; Gröger M; Maurer G; Huber K; Wojta J
J Mol Cell Cardiol; 2013 Jul; 60():16-26. PubMed ID: 23567618
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
4. Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
Veeraveedu PT; Sanada S; Okuda K; Fu HY; Matsuzaki T; Araki R; Yamato M; Yasuda K; Sakata Y; Yoshimoto T; Minamino T
Biochem Pharmacol; 2017 Aug; 138():73-80. PubMed ID: 28450225
[TBL] [Abstract][Full Text] [Related]
5. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.
Vanderheyden M; Goethals M; Verstreken S; De Bruyne B; Muller K; Van Schuerbeeck E; Bartunek J
J Am Coll Cardiol; 2004 Dec; 44(12):2349-54. PubMed ID: 15607397
[TBL] [Abstract][Full Text] [Related]
6. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
7. Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33.
Chen WY; Hong J; Gannon J; Kakkar R; Lee RT
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7249-54. PubMed ID: 25941360
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease.
Beltrán CJ; Núñez LE; Díaz-Jiménez D; Farfan N; Candia E; Heine C; López F; González MJ; Quera R; Hermoso MA
Inflamm Bowel Dis; 2010 Jul; 16(7):1097-107. PubMed ID: 20014018
[TBL] [Abstract][Full Text] [Related]
9. ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells.
Aoki S; Hayakawa M; Ozaki H; Takezako N; Obata H; Ibaraki N; Tsuru T; Tominaga S; Yanagisawa K
Mol Cell Biochem; 2010 Feb; 335(1-2):75-81. PubMed ID: 19756962
[TBL] [Abstract][Full Text] [Related]
10. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.
Shao D; Perros F; Caramori G; Meng C; Dormuller P; Chou PC; Church C; Papi A; Casolari P; Welsh D; Peacock A; Humbert M; Adcock IM; Wort SJ
Biochem Biophys Res Commun; 2014 Aug; 451(1):8-14. PubMed ID: 25003325
[TBL] [Abstract][Full Text] [Related]
11. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
Rehman SU; Mueller T; Januzzi JL
J Am Coll Cardiol; 2008 Oct; 52(18):1458-65. PubMed ID: 19017513
[TBL] [Abstract][Full Text] [Related]
13. ST2 pathogenetic profile in ambulatory heart failure patients.
Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
15. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.
Sabatine MS; Morrow DA; Higgins LJ; MacGillivray C; Guo W; Bode C; Rifai N; Cannon CP; Gerszten RE; Lee RT
Circulation; 2008 Apr; 117(15):1936-44. PubMed ID: 18378613
[TBL] [Abstract][Full Text] [Related]
16. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
17. Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?
Dhillon OS; Narayan HK; Khan SQ; Kelly D; Quinn PA; Squire IB; Davies JE; Ng LL
Int J Cardiol; 2013 Sep; 167(5):2182-8. PubMed ID: 22835988
[TBL] [Abstract][Full Text] [Related]
18. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.
Friedrich SP; Lorell BH; Rousseau MF; Hayashida W; Hess OM; Douglas PS; Gordon S; Keighley CS; Benedict C; Krayenbuehl HP
Circulation; 1994 Dec; 90(6):2761-71. PubMed ID: 7994819
[TBL] [Abstract][Full Text] [Related]
19. Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction.
Nagy AI; Hage C; Merkely B; Donal E; Daubert JC; Linde C; Lund LH; Manouras A
J Intern Med; 2018 Apr; 283(4):380-391. PubMed ID: 29430747
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.
Roth GA; Zimmermann M; Lubsczyk BA; Pilz J; Faybik P; Hetz H; Hacker S; Mangold A; Bacher A; Krenn CG; Ankersmit HJ
J Surg Res; 2010 Oct; 163(2):e79-83. PubMed ID: 20638676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
